These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9367357)

  • 1. Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system.
    Bielefeldt-Ohmann H; Beasley DW; Fitzpatrick DR; Aaskov JG
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2723-33. PubMed ID: 9367357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
    Delenda C; Staropoli I; Frenkiel MP; Cabanié L; Deubel V
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
    Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
    Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant.
    Saejung W; Puttikhunt C; Prommool T; Sojikul P; Tanaka R; Fujiyama K; Malasit P; Seki T
    J Biosci Bioeng; 2006 Oct; 102(4):333-9. PubMed ID: 17116581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis.
    Niu G; Pang Z; Guan C; Qi J; Li D
    Virus Res; 2015 Apr; 201():73-8. PubMed ID: 25697685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J; Cheah CY; AbuBakar S
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L
    APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
    Jaiswal S; Khanna N; Swaminathan S
    Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
    Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
    Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.
    Deubel V; Bordier M; Megret F; Gentry MK; Schlesinger JJ; Girard M
    Virology; 1991 Jan; 180(1):442-7. PubMed ID: 1984665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secreted expression of dengue virus type I envelope glycoprotein in 293T cells].
    Miao F; Li C; Zhang S; Wang XF; Li JD; Zhang QF; Liu QZ; Wei Y; Hang XT; Liang MF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):415-7. PubMed ID: 20718342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.
    Delenda C; Frenkiel MP; Deubel V
    Arch Virol; 1994; 139(1-2):197-207. PubMed ID: 7826210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.
    Men RH; Bray M; Lai CJ
    J Virol; 1991 Mar; 65(3):1400-7. PubMed ID: 1995950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.